Award

NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga)

THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)

This public procurement record has 1 release in its history.

Award

11 Jun 2021 at 10:40

Summary of the contracting process

The NHS Commissioning Board, operating under the name NHS England, has completed a tender process for the NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga). This procurement falls within the goods category and commenced on 1 June 2021, continuing for a period of seven months, with options for extensions up to a maximum of 13 months. The process is classified under CPV code 33651520, specifically related to immunoglobulins, and is primarily aimed at NHS facilities across various regions in the UK, including England, Scotland, and Northern Ireland. The procurement method employed was a limited negotiation without prior publication due to extreme urgency prompted by unforeseen global supply shortages. The contract, valued at £17,595,000, was awarded to Octapharma Limited on 10 June 2021.

This tender represents a significant opportunity for businesses that specialise in the production and supply of medical goods, particularly those focused on immunoglobulins. Companies with the capability to meet NHS standards for product quality and delivery would be well positioned to engage in future procurement processes under this framework, especially considering the ongoing demand for essential medical supplies in the wake of global health challenges. Engaging in such contracts not only allows businesses to expand their market reach but also contributes to public health initiatives, fostering long-term relationships with the NHS and associated healthcare providers.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga)

Notice Description

NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga). The framework will commence on 1 June 2021 for a period of 7 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months.

Lot Information

Lot 1

NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga). Period of framework agreement: 1 June 2021 to 31 December 2021 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months.

Options: Period of framework agreement: 1 June 2021 to 31 December 2021 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months.

Procurement Information

An urgent need to secure additional supply of Human Normal Immunoglobulin as a result of the ongoing global supply shortages

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02baf3
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/013184-2021
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Negotiated without publication of a contract notice
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33651520 - Immunoglobulins

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£17,595,000 £10M-£100M

Notice Dates

Publication Date
11 Jun 20214 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
9 Jun 20214 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)
Contact Name
Philip Grieve
Contact Email
philip.grieve@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Post Town
Warrington
Country
England

Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLI London, TLJ South East (England), TLK South West (England), TLM Scotland, TLN Northern Ireland

Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
1
Supplier Name

OCTAPHARMA

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-02baf3-2021-06-11T11:40:07+01:00",
    "date": "2021-06-11T11:40:07+01:00",
    "ocid": "ocds-h6vhtk-02baf3",
    "initiationType": "tender",
    "tender": {
        "id": "CM/PHS/21/5642",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga)",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33651520",
            "description": "Immunoglobulins"
        },
        "mainProcurementCategory": "goods",
        "description": "NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga). The framework will commence on 1 June 2021 for a period of 7 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months.",
        "lots": [
            {
                "id": "1",
                "description": "NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga). Period of framework agreement: 1 June 2021 to 31 December 2021 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months.",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                },
                "hasOptions": true,
                "options": {
                    "description": "Period of framework agreement: 1 June 2021 to 31 December 2021 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months."
                }
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33651520",
                        "description": "Immunoglobulins"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKC"
                    },
                    {
                        "region": "UKD"
                    },
                    {
                        "region": "UKE"
                    },
                    {
                        "region": "UKF"
                    },
                    {
                        "region": "UKG"
                    },
                    {
                        "region": "UKH"
                    },
                    {
                        "region": "UKI"
                    },
                    {
                        "region": "UKJ"
                    },
                    {
                        "region": "UKK"
                    },
                    {
                        "region": "UKM"
                    },
                    {
                        "region": "UKN"
                    }
                ],
                "deliveryLocation": {
                    "description": "ITT lists Purchasing Points. Framework intended for use by the NHS in England, Scotland Northern Ireland, Dept of Health & Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
                },
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Negotiated without publication of a contract notice",
        "techniques": {
            "hasFrameworkAgreement": true
        },
        "coveredBy": [
            "GPA"
        ],
        "procurementMethodRationaleClassifications": [
            {
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "id": "D_EXTREME_URGENCY",
                "description": "Extreme urgency brought about by events unforeseeable for the contracting authority/entity and in accordance with the strict conditions stated in the directive"
            }
        ],
        "procurementMethodRationale": "An urgent need to secure additional supply of Human Normal Immunoglobulin as a result of the ongoing global supply shortages"
    },
    "awards": [
        {
            "id": "013184-2021-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-19257",
                    "name": "Octapharma Limited"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-2505",
            "name": "The NHS Commissioning Board (operating under the name of NHS England)",
            "identifier": {
                "legalName": "The NHS Commissioning Board (operating under the name of NHS England)"
            },
            "address": {
                "streetAddress": "2nd Floor, Rutland House",
                "locality": "Runcorn",
                "region": "UK",
                "postalCode": "WA7 2ES",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Philip Grieve",
                "email": "philip.grieve@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "http://www.england.nhs.uk",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "MINISTRY",
                        "description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-19257",
            "name": "Octapharma Limited",
            "identifier": {
                "legalName": "Octapharma Limited"
            },
            "address": {
                "locality": "Manchester",
                "region": "UK",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-495",
            "name": "The High Court",
            "identifier": {
                "legalName": "The High Court"
            },
            "address": {
                "locality": "London",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-2505",
        "name": "The NHS Commissioning Board (operating under the name of NHS England)"
    },
    "contracts": [
        {
            "id": "013184-2021-1",
            "awardID": "013184-2021-1",
            "status": "active",
            "value": {
                "amount": 17595000,
                "currency": "GBP"
            },
            "dateSigned": "2021-06-10T00:00:00+01:00"
        }
    ],
    "language": "en"
}